These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

66 related items for PubMed ID: 9193747

  • 1. Outpatient total body irradiation for pediatric patients undergoing stem cell transplantation.
    Dagher R, Robertson KA, Lucas KG, Emanuel D, Smith FO.
    Bone Marrow Transplant; 1997 Jun; 19(11):1065-7. PubMed ID: 9193747
    [Abstract] [Full Text] [Related]

  • 2. Outpatient total body irradiation as a component of a comprehensive outpatient transplant program.
    Bredeson C, Perry G, Martens C, McDiarmid S, Bence-Bruckler I, Atkins H, Serna D, Hopkins H, Mikhael J, Genest P, Huebsch L.
    Bone Marrow Transplant; 2002 Apr; 29(8):667-71. PubMed ID: 12180111
    [Abstract] [Full Text] [Related]

  • 3. Outpatient total body irradiation prior to bone marrow transplantation in pediatric patients: a feasibility analysis.
    Applegate GL, Mittal BB, Kletzel M, Morgan E, Johnson P, Danner K, Marymont MH.
    Bone Marrow Transplant; 1998 Apr; 21(7):651-2. PubMed ID: 9578303
    [Abstract] [Full Text] [Related]

  • 4. Safety and cost-effectiveness of outpatient total body irradiation in pediatric patients undergoing stem cell transplantation.
    Farah RA, Aquino VM, Munoz LL, Sandler ES.
    J Pediatr Hematol Oncol; 1998 Apr; 20(4):319-21. PubMed ID: 9703004
    [Abstract] [Full Text] [Related]

  • 5. Autologous hematopoietic stem cell transplants that utilize total body irradiation can safely be carried out entirely on an outpatient basis.
    Stiff P, Mumby P, Miler L, Rodriguez T, Parthswarthy M, Kiley K, Porter N, Batiste R, Wojtowitz S, Lichtenstein S, Fox-Geiman M, Toor A.
    Bone Marrow Transplant; 2006 Dec; 38(11):757-64. PubMed ID: 17057729
    [Abstract] [Full Text] [Related]

  • 6. Very late nonfatal consequences of fractionated TBI in children undergoing bone marrow transplant.
    Faraci M, Barra S, Cohen A, Lanino E, Grisolia F, Miano M, Foppiano F, Sacco O, Cabria M, De Marco R, Stella G, Dallorso S, Bagnasco F, Vitale V, Dini G, Haupt R.
    Int J Radiat Oncol Biol Phys; 2005 Dec 01; 63(5):1568-75. PubMed ID: 15990246
    [Abstract] [Full Text] [Related]

  • 7. Randomized trial of busulfan vs total body irradiation containing conditioning regimens for children with acute lymphoblastic leukemia: a Pediatric Blood and Marrow Transplant Consortium study.
    Bunin N, Aplenc R, Kamani N, Shaw K, Cnaan A, Simms S.
    Bone Marrow Transplant; 2003 Sep 01; 32(6):543-8. PubMed ID: 12953124
    [Abstract] [Full Text] [Related]

  • 8. Controlling conditioning-related emesis in children undergoing bone marrow transplantation.
    Mehta NH, Reed CM, Kuhlman C, Weinstein HJ, Parsons SK.
    Oncol Nurs Forum; 1997 Oct 01; 24(9):1539-44. PubMed ID: 9348595
    [Abstract] [Full Text] [Related]

  • 9. [Efficacy of granisetron, a 5-HT3 antagonist, in the prevention of nausea and vomiting induced by conditioning for hematopoietic stem cell transplantation].
    Hirabayashi N, Goto S, Morishima Y, Sao H, Matsuyama T, Kodera Y, Yamada H, Horibe K, Yano K, Kojima H, Ogura M, Tanimoto M, Morishita Y, Yazaki M, Utsumi M, Nagata K, Kato Y, Naoe T, Saito H.
    Rinsho Ketsueki; 1998 Jan 01; 39(1):21-6. PubMed ID: 9492549
    [Abstract] [Full Text] [Related]

  • 10. Allogeneic bone marrow transplantation for children with acute leukemia: long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated total body irradiation.
    Gordon BG, Warkentin PI, Strandjord SE, Abromowitch M, Bayever E, Harper JL, Coccia PF.
    Bone Marrow Transplant; 1997 Jul 01; 20(1):5-10. PubMed ID: 9232249
    [Abstract] [Full Text] [Related]

  • 11. Double-blind, randomized, parallel-group study on the efficacy and safety of oral granisetron and oral ondansetron in the prophylaxis of nausea and vomiting in patients receiving hyperfractionated total body irradiation.
    Spitzer TR, Friedman CJ, Bushnell W, Frankel SR, Raschko J.
    Bone Marrow Transplant; 2000 Jul 01; 26(2):203-10. PubMed ID: 10918432
    [Abstract] [Full Text] [Related]

  • 12. Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine.
    Mori T, Aisa Y, Watanabe R, Yamazaki R, Kato J, Shimizu T, Shigematsu N, Kubo A, Yajima T, Hibi T, Ikeda Y, Okamoto S.
    Biol Blood Marrow Transplant; 2008 Jun 01; 14(6):651-7. PubMed ID: 18489990
    [Abstract] [Full Text] [Related]

  • 13. Outpatient total body irradiation for bone marrow transplantation.
    Algara M, Valls A, Vivancos P, Grañena A.
    Bone Marrow Transplant; 1994 Sep 01; 14(3):381-2. PubMed ID: 7994258
    [Abstract] [Full Text] [Related]

  • 14. Comparative outcome of hematopoietic stem cell transplantation for pediatric acute lymphoblastic leukemia following cyclophosphamide and total body irradiation or VP16 and total body irradiation conditioning regimens.
    Gassas A, Sung L, Saunders EF, Doyle JJ.
    Bone Marrow Transplant; 2006 Dec 01; 38(11):739-43. PubMed ID: 17013424
    [Abstract] [Full Text] [Related]

  • 15. Total body irradiation, fludarabine, melphalan, and allogeneic hematopoietic stem cell transplantation for advanced pediatric hematologic malignancies.
    Petropoulos D, Worth LL, Mullen CA, Madden R, Mahajan A, Choroszy M, Ha CS, Champlin RC, Chan KW.
    Bone Marrow Transplant; 2006 Mar 01; 37(5):463-7. PubMed ID: 16435013
    [Abstract] [Full Text] [Related]

  • 16. Antiemetic efficacy of three serotonin antagonists during high-dose chemotherapy and autologous stem cell transplantation in malignant lymphoma.
    Slabý J, Trnený M, Procházka B, Klener P.
    Neoplasma; 2000 Mar 01; 47(5):319-22. PubMed ID: 11130251
    [Abstract] [Full Text] [Related]

  • 17. Utility of cranial boost in addition to total body irradiation in the treatment of high risk acute lymphoblastic leukemia.
    Alexander BM, Wechsler D, Braun TM, Levine J, Herman J, Yanik G, Hutchinson R, Pierce LJ.
    Int J Radiat Oncol Biol Phys; 2005 Nov 15; 63(4):1191-6. PubMed ID: 15978741
    [Abstract] [Full Text] [Related]

  • 18. Double-blind comparative trial of oral ondansetron versus oral granisetron versus IV ondansetron in the prevention of nausea and vomiting associated with highly emetogenic preparative regimens prior to stem cell transplantation.
    Fox-Geiman MP, Fisher SG, Kiley K, Fletcher-Gonzalez D, Porter N, Stiff P.
    Biol Blood Marrow Transplant; 2001 Nov 15; 7(11):596-603. PubMed ID: 11760147
    [Abstract] [Full Text] [Related]

  • 19. Allogeneic stem cell transplantation in patients with Fanconi's anemia and myelodysplasia or leukemia utilizing low-dose cyclophosphamide and total body irradiation.
    Ayas M, Al-Jefri A, Al-Mahr M, Rifai S, Moussa E, Karaoui M, Roberts G, El-Solh H.
    Bone Marrow Transplant; 2004 Jan 15; 33(1):15-7. PubMed ID: 14578932
    [Abstract] [Full Text] [Related]

  • 20. Fludarabine allows dose reduction for total body irradiation in pediatric hematopoietic stem cell transplantation.
    Kornguth DG, Mahajan A, Woo S, Chan KW, Antolak J, Ha CS.
    Int J Radiat Oncol Biol Phys; 2007 Jul 15; 68(4):1140-4. PubMed ID: 17379444
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.